Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...

Brian Holmes is the first man in the UK and the fifth in the world to receive the treatment.

Prostate cancer is the leading cancer among Kenyan men, with an estimated 3,582 men being diagnosed with the disease at some ...

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who ...

They use the body's own immune system to detect and kill cancer cells "Immunotherapies have been very promising and has ...

One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others ...

Leapman, MD, MHS, associate professor of urology at Yale University, addresses a critical and often overlooked limitation in the current landscape of prostate cancer biomarkers: while these tools have ...

Historically, treatment for metastatic prostate cancer relied heavily on androgen deprivation therapy (ADT) alone. Over time, ...

MRT-2359 is an investigational, orally bioavailable, GSPT1-directed molecular glue degrader that has shown compelling clinical activity in combination with androgen receptor (AR) inhibition in heavily ...